Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Jan-23 8:56 PM View:  | Gelone Steven P. Director | Nabriva Therapeutics Plc (NBRV) | 29-Jan-23 | Payment of Exercise | 140 | $1.50 | $210.00 | (< 1%) 14.42K to 14.28K | |
| 31-Jan-23 8:55 PM View: | Schroeder Theodore R Director | Nabriva Therapeutics Plc (NBRV) | 29-Jan-23 | Payment of Exercise | 431 | $1.50 | $646.50 | (3%) 12.42K to 11.99K | |
| 10-Jan-23 5:58 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Jan-23 | Payment of Exercise | 5 | $1.30 | $6.50 | (< 1%) 14.43K to 14.42K | |
| 10-Jan-23 5:56 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Jan-23 | Payment of Exercise | 11 | $1.30 | $14.30 | (< 1%) 12.43K to 12.42K | |
| 04-Jan-23 6:08 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 31-Dec-22 | Payment of Exercise | 3 | $1.89 | $5.67 | (< 1%) 14.43K to 14.43K | |
| 04-Jan-23 6:09 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 31-Dec-22 | Payment of Exercise | 5 | $1.89 | $9.45 | (< 1%) 12.44K to 12.43K | |
| 08-Dec-22 4:34 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Dec-22 | Payment of Exercise | 9 | $2.02 | $18.18 | (< 1%) 12.45K to 12.44K | |
| 08-Dec-22 4:37 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Dec-22 | Payment of Exercise | 4 | $2.02 | $8.08 | (< 1%) 14.44K to 14.43K | |
| 02-Dec-22 5:17 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 30-Nov-22 | Payment of Exercise | 3 | $2.25 | $6.75 | (< 1%) 14.44K to 14.44K | |
| 02-Dec-22 5:15 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 30-Nov-22 | Payment of Exercise | 5 | $2.25 | $11.25 | (< 1%) 12.45K to 12.45K | |
| 08-Nov-22 5:24 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Nov-22 | Payment of Exercise | 10 | $2.24 | $22.39 | (< 1%) 12.46K to 12.45K | |
| 08-Nov-22 5:26 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Nov-22 | Payment of Exercise | 4 | $2.24 | $8.96 | (< 1%) 14.44K to 14.44K | |
| 01-Nov-22 5:08 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 31-Oct-22 | Payment of Exercise | 5 | $2.54 | $12.70 | (< 1%) 12.46K to 12.46K | |
| 01-Nov-22 5:06 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 31-Oct-22 | Payment of Exercise | 3 | $2.54 | $7.62 | (< 1%) 14.45K to 14.44K | |
| 11-Oct-22 5:00 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Oct-22 | Payment of Exercise | 4 | $2.72 | $10.88 | (< 1%) 14.45K to 14.45K | |
| 11-Oct-22 5:03 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Oct-22 | Payment of Exercise | 9 | $2.72 | $24.48 | (< 1%) 12.47K to 12.46K | |
| 04-Oct-22 9:31 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 30-Sep-22 | Payment of Exercise | 5 | $2.08 | $10.40 | (< 1%) 12.48K to 12.47K | |
| 04-Oct-22 9:36 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 30-Sep-22 | Payment of Exercise | 3 | $2.08 | $6.24 | (< 1%) 14.45K to 14.45K | |
| 07-Sep-22 6:00 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Sep-22 | Payment of Exercise | 225 | $0.16 | $35.24 | (< 1%) 312.2K to 311.98K | |
| 07-Sep-22 5:57 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Sep-22 | Payment of Exercise | 89 | $0.16 | $13.94 | (< 1%) 361.4K to 361.31K | |
| 01-Sep-22 6:35 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 31-Aug-22 | Payment of Exercise | 61 | $0.16 | $10.04 | (< 1%) 361.46K to 361.4K | |
| 01-Sep-22 6:38 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 31-Aug-22 | Payment of Exercise | 107 | $0.16 | $17.61 | (< 1%) 312.31K to 312.2K | |
| 08-Aug-22 5:44 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Aug-22 | Payment of Exercise | 225 | $0.18 | $41.56 | (< 1%) 312.53K to 312.31K | |
| 08-Aug-22 5:45 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Aug-22 | Payment of Exercise | 89 | $0.18 | $16.44 | (< 1%) 361.55K to 361.46K | |
| 04-Aug-22 6:24 PM View: | Burgess Daniel D Director | Nabriva Therapeutics Plc (NBRV) | 02-Aug-22 | Sale | 11,341 | $0.19 | $2,155.92 | (52%) 21.73K to 10.38K | |
| 04-Aug-22 6:22 PM View: | Broom Colin Md Director | Nabriva Therapeutics Plc (NBRV) | 02-Aug-22 | Sale | 5,339 | $0.19 | $1,015.48 | (13%) 41.86K to 36.52K | |
| 04-Aug-22 6:20 PM View: | Webster Stephen W Director | Nabriva Therapeutics Plc (NBRV) | 02-Aug-22 | Sale | 7,826 | $0.19 | $1,486.94 | (41%) 19.27K to 11.45K | |
| 04-Aug-22 6:19 PM View: | Corrigan Mark Director | Nabriva Therapeutics Plc (NBRV) | 02-Aug-22 | Sale | 10,297 | $0.19 | $1,956.43 | (59%) 17.5K to 7.2K | |
| 03-Aug-22 9:47 PM View: | Bourdow Carrie L. Director | Nabriva Therapeutics Plc (NBRV) | 01-Aug-22 | Sale | 8,540 | $0.17 | $1,486.81 | (46%) 18.47K to 9.93K | |
| 03-Aug-22 9:48 PM View: | Rowland Charles A Jr Director | Nabriva Therapeutics Plc (NBRV) | 01-Aug-22 | Sale | 8,496 | $0.17 | $1,486.80 | (36%) 23.77K to 15.28K | |
| 03-Aug-22 9:46 PM View: | Dalton Lisa Director | Nabriva Therapeutics Plc (NBRV) | 31-Jul-22 | Payment of Exercise | 8,400 | $0.18 | $1,503.60 | (48%) 17.5K to 9.1K | |
| 03-Aug-22 9:45 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 31-Jul-22 | Payment of Exercise | 107 | $0.18 | $19.15 | (< 1%) 312.64K to 312.53K | |
| 03-Aug-22 9:43 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 31-Jul-22 | Payment of Exercise | 61 | $0.18 | $10.92 | (< 1%) 361.61K to 361.55K | |
| 07-Jul-22 4:10 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Jul-22 | Payment of Exercise | 89 | $0.18 | $16.22 | (< 1%) 361.7K to 361.61K | |
| 07-Jul-22 4:11 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Jul-22 | Payment of Exercise | 225 | $0.18 | $40.99 | (< 1%) 312.87K to 312.64K | |
| 01-Jul-22 6:08 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 30-Jun-22 | Payment of Exercise | 107 | $0.18 | $19.47 | (< 1%) 312.97K to 312.87K | |
| 01-Jul-22 6:06 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 30-Jun-22 | Payment of Exercise | 61 | $0.18 | $11.10 | (< 1%) 361.76K to 361.7K | |
| 07-Jun-22 4:47 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Jun-22 | Payment of Exercise | 225 | $0.20 | $45.00 | (< 1%) 313.2K to 312.97K | |
| 07-Jun-22 4:46 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Jun-22 | Payment of Exercise | 89 | $0.20 | $17.80 | (< 1%) 361.85K to 361.76K | |
| 02-Jun-22 4:09 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 31-May-22 | Payment of Exercise | 61 | $0.21 | $12.60 | (< 1%) 361.91K to 361.85K | |
| 02-Jun-22 4:10 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 31-May-22 | Payment of Exercise | 107 | $0.21 | $22.11 | (< 1%) 313.31K to 313.2K | |
| 09-May-22 6:32 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-May-22 | Payment of Exercise | 225 | $0.26 | $58.50 | (< 1%) 313.53K to 313.31K | |
| 09-May-22 6:33 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-May-22 | Payment of Exercise | 89 | $0.26 | $23.14 | (< 1%) 362.0K to 361.91K | |
| 03-May-22 4:59 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 30-Apr-22 | Payment of Exercise | 107 | $0.31 | $33.17 | (< 1%) 313.64K to 313.53K | |
| 03-May-22 4:58 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 30-Apr-22 | Payment of Exercise | 61 | $0.31 | $18.91 | (< 1%) 362.06K to 362.0K | |
| 08-Apr-22 4:15 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 06-Apr-22 | Payment of Exercise | 89 | $0.41 | $36.49 | (< 1%) 362.15K to 362.06K | |
| 08-Apr-22 4:16 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Apr-22 | Payment of Exercise | 219 | $0.41 | $89.79 | (< 1%) 313.86K to 313.64K | |
| 04-Apr-22 6:27 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 31-Mar-22 | Payment of Exercise | 104 | $0.42 | $43.68 | (< 1%) 313.96K to 313.86K | |
| 04-Apr-22 6:26 PM View: | Gelone Steven P. President and COO Director | Nabriva Therapeutics Plc (NBRV) | 31-Mar-22 | Payment of Exercise | 61 | $0.42 | $25.62 | (< 1%) 362.21K to 362.15K | |
| 08-Mar-22 4:12 PM View: | Schroeder Theodore R Chief Executive Officer Director | Nabriva Therapeutics Plc (NBRV) | 06-Mar-22 | Payment of Exercise | 263 | $0.43 | $113.09 | (< 1%) 314.22K to 313.96K |
